Observational Study
Copyright ©The Author(s) 2025.
World J Hepatol. Apr 27, 2025; 17(4): 105660
Published online Apr 27, 2025. doi: 10.4254/wjh.v17.i4.105660
Table 1 General clinical characteristics of the study population
Variables
HC (n = 29)
LC (n = 61)
χ²/t
P value
Sex (male)23.00 (79.30%)50.00 (82.00%)0.2480.763
Age (years)51.65 ± 8.3453.89 ± 9.38-1.0910.278
WBC (109/L)5.58 ± 1.214.60 ± 2.482.0240.046
HB (g/L)146.22 ± 35.68110.82 ± 29.994.918< 0.001
PLT (109/L)230.10 ± 54.88109.62 ± 73.077.877< 0.001
Alb (g/L)47.09 ± 4.7432.87 ± 6.929.990< 0.001
ALT (U/L)20.59 ± 6.9243.64 ± 6.92-1.8030.075
AST (U/L)23.00 ± 9.3958.62 ± 60.48-3.1450.002
ALP (U/L)70.28 ± 15.33117.16 ± 52.84-4.673< 0.001
γ-GGT (U/L)23.17 ± 12.72123.61 ± 333.17-1.6180.109
TBIL (umol/L)10.81 ± 3.5265.82 ± 93.82-3.1470.002
Cr (umol/L)71.25 ± 8.7971.93 ± 28.85-0.1490.882
Table 2 Analysis of the correlation between serum interleukin-36 subfamily cytokines and clinical indicators in study participants
Variables
IL-36α
IL-36γ
IL-36Ra
IL-38
R value
P value
R value
P value
R value
P value
R value
P value
WBC (109/L)0.0050.9630.0470.661-0.1110.2980.0480.655
HB (g/L)-0.2960.005-0.2450.020-0.2400.023-0.1860.079
PLT (109/L)-0.3450.001-0.2750.009-0.2550.015-0.1530.151
Alb (g/L)0.525< 0.001-0.437< 0.001-0.1850.082-0.3460.001
ALT (U/L)0.1800.090-0.1870.077-0.0200.8520.1650.119
AST (U/L)0.395< 0.0010.584< 0.0010.1720.1040.495< 0.001
ALP (U/L)0.482< 0.0010.354< 0.0010.1360.2020.406< 0.001
γ-GGT (U/L)0.437< 0.001-0.0230.8280.0360.736-0.0430.689
TBIL (umol/L)0.471< 0.0010.559< 0.0010.2280.0310.540< 0.001
Cr (umol/L)-0.0800.451-0.0240.823-0.1870.0780.0030.981
Child-pug score0.4180.0010.3870.0020.2030.1170.3800.003